biotech stocks

“Taking on a challenge is a lot like riding a horse; if you're comfortable while you're doing it, you're probably doing it wrong” Ted Lasso

“The secret to wealth is finding the asymmetric payoff—small risk, big reward” Nassim Taleb Introduction When this writer first set about a career in finance we were...

Firetrail's Australian Small Companies Fund has shot the lights out over the past 12 months. Here, they reveal the stocks they are backing.

LTR Pharma is a clinical-stage pharmaceutical company, commercialising a world first in erectile dysfunction, Spontan, a PDE5 nasal spray.

Just because CSL hadn’t factored in financial benefit from CSL112, it doesn’t mean the market hadn’t.

It's a challenging time for growth investors. Plenty of fund managers have posted negative returns, but Michael Frazis remains optimistic. In this wire he, spells out...

Sector Overview The IIR Pharma & Biotech Index increased 2.9% in the month of June, in line with the broader market with the ASX All Ordinaries Accumulation Index up...

It hasn’t been a good year for Avita Therapeutics (ASX:AVH). The med-tech stock is the worst performer among Livewire readers’ 10 most-tipped small caps, down nearly...

Both IXC and PAR (Paradigm Biopharmaceuticals) are repurposing existing drugs, successfully completed Phase II trials, completed recent capital raises (both...